Lymphocyte In Vitro Response to Human Giant Cell Tumors
- 1 May 1996
- journal article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 326 (326) , 55-62
Abstract
Peripheral blood lymphocytes and tumor cells were obtained from 31 patients with giant cell tumors of bone and cocultured in vitro in a mixed lymphocyte tumor cell assay. The lymphocyte proliferative response was measured by incorporation of 3H thymidine. Also, the patients' lymphocytes were tested for proliferative reactivity to phytohemagglutinin and allogenic lymphocytes to evaluate nontumor immunologic competence. Mixed lymphocyte tumor cell assays showed higher lymphocyte stimulation in patients with Stage I as compared with Stages II and III giant cell tumors. The proliferative response was blocked partially when the patients' sera was used to supplement the cultures. Lymphocytes from patients with a recurring tumor showed lower responses, but the differences with primary tumors were not significant. This evidence suggests that there is an immune response to giant cell tumor antigens and that this response might be related to the aggressiveness of the tumor.Keywords
This publication has 19 references indexed in Scilit:
- Expression of interleukin-2 receptor on blood lymphocytes stimulated with allogeneic lymphocytes or autologous tumor cellsCancer Immunology, Immunotherapy, 1990
- Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitroCancer Immunology, Immunotherapy, 1990
- Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cellsCancer Immunology, Immunotherapy, 1989
- In vitro generation of tumour-specific lymphocyte reactivity to colonic carcinoma cellsCancer Immunology, Immunotherapy, 1987
- Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgeryCancer Immunology, Immunotherapy, 1986
- DR antigens expressed on tumor cells do not contribute to the blastogenetic response of autologous T cellsCancer Immunology, Immunotherapy, 1985
- The human mixed lymphocyte-tumor cell interaction testCancer Immunology, Immunotherapy, 1984
- Activation of lymphocyte anti-tumor responses in man. Towards an understanding of effector cell heterogeneity?Cancer Immunology, Immunotherapy, 1984
- Primary but not metastatic human melanomas expressing dr antigens stimulate autologous lymphocytesInternational Journal of Cancer, 1984
- Lymphocyte blastogenesis induced by autochthonous human solid tumor cells: Relationship to stage of disease and serum factorsCancer, 1974